Ethene, homopolymer, oxidized
Common Name: |
Ethene, homopolymer, oxidized |
IUPAC Name: |
6-hydroxy-5-methyl-4,11-dioxoundecanoic acid |
Molecular Formula: |
C12H20O5 |
SMILES: |
CC(C(CCCCC=O)O)C(=O)CCC(=O)O |
Inchi: |
1S/C12H20O5/c1-9(11(15)6-7-12(16)17)10(14)5-3-2-4-8-13/h8-10,14H,2-7H2,1H3,(H,16,17) |
Inchi Key: |
AZUZXOSWBOBCJY-UHFFFAOYSA-N |
Cas No: |
68441-17-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
244.28 |
Mass (g/mol) |
244.131 |
Molar Refractivity |
63.13 |
Net Charge |
|
HBD |
2 |
HBA |
5 |
Rt Bonds |
10 |
Rings |
|
TPSA |
91.67 |
Hetero Atoms |
|
Heavy Atoms |
17 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.75 |
LogP |
|
iLOGP |
1.57 |
XLOGP3 |
-0.23 |
WLOGP |
1.18 |
MLOGP |
0.39 |
ESOL Log S |
-0.55 |
ESOL Solubility (mg/ml) |
68.9 |
ESOL Solubility (mol/l) |
0.282 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.24 |
Ali Solubility (mg/ml) |
14.1 |
Ali Solubility (mol/l) |
0.06 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.50 |
Silicos-IT Solubility (mg/ml) |
7.8 |
Silicos-IT Solubility (mol/l) |
0.03 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-7.95 |
Bioavailability Score |
0.56 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.574 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.729 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
1 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |